伴侶動物疫苗市場：依產品種類、動物種類、通路和地區分類。

Companion Animal Vaccine Market, By Product Type, By Species Type , By Distribution Channel, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，伴侶動物疫苗市場規模將達到40.9億美元，到2033年將達到65.6億美元。預計從2026年到2033年，該市場將以7.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	40.9億美元
目標期限：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.00%	2033年市場規模預測：	65.6億美元

伴侶動物疫苗在以經濟有效的方式改善伴侶動物健康方面發揮著至關重要的作用。這些疫苗對於減少動物間或動物與人類之間傳播的病毒性疾病也至關重要。美國食品藥物管理局（FDA）獸藥中心（CVM）核准用於伴侶動物（寵物）如犬、貓和馬以及肉類用動物（如牛、豬和雞）的藥物。此外，為預防伴侶動物病毒性疾病等疾病而不斷加強的監管力度預計將在預測期內推動全球伴侶動物市場的成長。例如，2016年，美國動物醫院協會（AAHA）推出了一個由獸醫腫瘤學專家組成的工作小組，旨在製定一套指南，幫助獸醫團隊與寵物飼主合作，制定個人化的治療方案，以提高癌症寵物的生命品質。

市場動態

預計在核准和上市數量不斷增加；市場主要參與者採取收購和合作等非內部成長策略；以及新疫苗研發力度的活性化。例如，2019年3月，法國動物用藥品公司維克(Virbac)推出了利什曼原蟲症。

此外，2018 年 6 月，碩騰公司獲得了美國農業部的上市許可，其產品「Fostera Gold PCV」是首個含有兩種豬環狀病毒2 型 (PCV2) 基因型的單價疫苗，用於養豬核准。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球伴侶動物疫苗市場的主要參與者進行了分析：公司概況、財務績效、產品系列、市場佔有率、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的市場擴張和行銷策略做出明智的決策。
這份全球伴侶動物疫苗市場報告旨在為行業內的各種相關人員提供參考，包括投資者、產品開發商和製造商、經銷商、醫療機構、研究機構、新參與企業和金融分析師。
透過利用全球伴侶動物疫苗市場分析中使用的各種策略矩陣進行決策，相關人員可以從中受益匪淺。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as

第9章

參考
調查方法

簡介目錄

Product Code: CMI3387

Companion Animal Vaccine Market is estimated to be valued at USD 4.09 Bn in 2026 and is expected to reach USD 6.56 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.09 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.00%	2033 Value Projection:	USD 6.56 Bn

Companion animal vaccines play an important role in improving the health of companion animals in a cost effective manner. These vaccines are also important for reducing viral diseases transmitted from animals to animals or animals to humans. The U.S. FDA Center for Veterinary Medicine (CVM) approves drugs for companion (pet) animals such as dogs, cats, and horses and for food-producing animals such as cattle, pigs, and chickens. Moreover, increasing initiatives from regulatory authorities for prevention of diseases such as viral diseases in companion animals are expected to boost the global companion animal market growth over the forecast period. For instance, in 2016, The American Animal Hospital Association (AAHA) has commissioned a task force of veterinary oncology experts to develop a set of guidelines that will help veterinary teams work with pet owners for tailored treatment plans that will improve the quality of life of pets with cancer.

Market Dynamics

The increasing approval and launch of novel companion vaccines, adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, and rising research and development of novel vaccines are expected to drive the growth of global companion animal vaccine market over the forecast period. For instance, in March 2019, Virbac, a French animal care company, launched a vaccine called CANILEISH to prevent canine leishmaniosis, due to the increasing prevalence of canine leishmaniosis in several regions across the globe, especially in Southern Europe and South America.

Moreover, in June 2018, Zoetis received approval from the U.S. Department of Agriculture for marketing its first monovalent vaccine Fostera Gold PCV, used in the pork industry for swine that includes two genotypes of porcine circovirus type 2 (PCV2).

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global companion animal vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc, HIPRA, Biogenesis Bago, and Ourofino Animal Health.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
The global companion animal vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global companion animal vaccine market.

Market Segmentation

Global Companion Animal Vaccine Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Attenuated Live Vaccine
Conjugate Vaccine
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
DNA Vaccine
Recombinant Vaccine
Global Companion Animal Vaccine Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
Canine
Feline
Equine
Others
Global Companion Animal Vaccine Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institute
Others
Global Companion Animal Vaccine Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Elanco Animal Health Incorporated
Boehringer Ingelheim GmbH
Ceva Ltd.
Merck & Co. Inc.
Virbac
Zoetis Inc.
HIPRA
Biogenesis Bago
Ourofino Animal Health
Croda International Plc
KM Biologics
Indian Immunological Ltd.
Sinovac
Kyoto Biken vLaboratories, Inc.
HESTER BIOSCIENCES LIMITED
Calier
Bioveta

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Product Launches/Approvals
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Companion Animal Vaccine Market, By Product Type, 2021- 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trend
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trend

5. Global Companion Animal Vaccine Market, By Species Type, 2021- 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

6. Global Companion Animal Vaccine Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Companion Animal Vaccine Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Elanco Animal Health Incorporated
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ceva Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck & Co. Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Virbac
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Zoetis Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- HIPRA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biogenesis Bago
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ourofino Animal Health.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Croda International Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- KM Biologics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Indian Immunologicals Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sinovac
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Kyoto Biken Laboratories, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- HESTER BIOSCIENCES LIMITED
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Calier
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bioveta, a.s
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies